LGC labs group seeks £500m for secondary LBO by KKR
LGC Group, the UK life sciences company, will hold a bank meeting on January 13 for £500m of debt to finance its sale by Bridgepoint to KKR.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts